Overall, the results of the randomized
trial indicate that Capecitabine 500mg is an effective and well-tolerated
treatment option for advanced colorectal and metastatic breast cancer. It is
associated with significantly improved progression-free survival, overall
survival, and fewer adverse events compared to combination treatment. Thus, Capecitabine
500mg is a viable option for the treatment of these cancers.
Insight into Capecitabine 500 mg
Capecitabine 500mg is a viable treatment option for a variety of different cancers. It is considered a targeted therapy, meaning that it is designed to block the growth or spread of cancer cells while minimizing damage to other healthy cells in the body. Capecitabine 500mg Tablet is used to treat a wide range of different tumors including colorectal, breast, stomach and pancreatic cancer, neuroendocrine tumors, and squamous cell carcinoma of the head and neck. It works by stopping the growth of cancer cells and allowing healthy cells to remain unaffected. By blocking the growth of cancer cells, Capecitabine helps stop the progression of the disease.
